Healthcare provider profile · identity verified

Reza Tabibi, MD

Geriatric Medicine · KIRKLAND, WA · NPI 1053450627

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	665	180
Rosuvastatin Calcium	Rosuvastatin Calcium	614	151
Atorvastatin Calcium	Atorvastatin Calcium	405	105
Escitalopram Oxalate	Escitalopram Oxalate	390	80
Losartan Potassium	Losartan Potassium	390	104
Levothyroxine Sodium	Levothyroxine Sodium	389	95
Metoprolol Succinate	Metoprolol Succinate	299	75
Omeprazole	Omeprazole	233	64
Eliquis	Apixaban	221	53
Furosemide	Furosemide	204	51
Tamsulosin Hcl	Tamsulosin Hcl	187	52
Gabapentin	Gabapentin	185	52
Lisinopril	Lisinopril	180	45
Pantoprazole Sodium	Pantoprazole Sodium	156	39
Hydralazine Hcl	Hydralazine Hcl	151	28
Lorazepam	Lorazepam	146	39
Olmesartan Medoxomil	Olmesartan Medoxomil	144	35
Citalopram Hbr	Citalopram Hydrobromide	139	27
Quetiapine Fumarate	Quetiapine Fumarate	134	32
Finasteride	Finasteride	126	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	126	38
Metformin Hcl	Metformin Hcl	121	30
Duloxetine Hcl	Duloxetine Hcl	117	29
Sertraline Hcl	Sertraline Hcl	112	31
Trazodone Hcl	Trazodone Hcl	107	27
Celecoxib	Celecoxib	102	27
Donepezil Hcl	Donepezil Hcl	101	29
Buspirone Hcl	Buspirone Hcl	99	22
Potassium Chloride	Potassium Chloride	93	21
Myrbetriq	Mirabegron	92	22
Diclofenac Sodium	Diclofenac Sodium	84	22
Memantine Hcl	Memantine Hcl	83	19
Jardiance	Empagliflozin	77	19
Carvedilol	Carvedilol	69	23
Allopurinol	Allopurinol	67	19
Bupropion Xl	Bupropion Hcl	65	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	65	18
Mirtazapine	Mirtazapine	64	20
Pravastatin Sodium	Pravastatin Sodium	64	19
Fluticasone Propionate	Fluticasone Propionate	63	34
Fentanyl	Fentanyl	62	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	62	17
Metoprolol Tartrate	Metoprolol Tartrate	62	20
Albuterol Sulfate Hfa	Albuterol Sulfate	59	26
Glipizide Er	Glipizide	57	suppressed
Metformin Hcl Er	Metformin Hcl	56	15
Oxycodone Hcl	Oxycodone Hcl	51	16
Estradiol	Estradiol	47	20
Risperidone	Risperidone	47	11
Ozempic	Semaglutide	44	suppressed
Tramadol Hcl	Tramadol Hcl	42	14
Prednisone	Prednisone	41	19
Xarelto	Rivaroxaban	40	12
Torsemide	Torsemide	39	12
Cefdinir	Cefdinir	38	34
Zolpidem Tartrate	Zolpidem Tartrate	37	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Famotidine	Famotidine	36	13
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Irbesartan	Irbesartan	34	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	16
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	30
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Atenolol	Atenolol	24	suppressed
Folic Acid	Folic Acid	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Lidocaine	Lidocaine	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Alprazolam	Alprazolam	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Loperamide	Loperamide Hcl	20	suppressed
Risedronate Sodium	Risedronate Sodium	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Azithromycin	Azithromycin	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Ketoconazole	Ketoconazole	17	11
Lovastatin	Lovastatin	17	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	11
Glipizide	Glipizide	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Simvastatin	Simvastatin	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Digoxin	Digoxin	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error